T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Valley National Bancorp
VLY
$8.3B
| $13.1M | ﹤0.01% |
1,435,745
-485,870
| -25% | -$4.55M |
|
1227
NetApp
NTAP
$40.2B
| $13.1M | ﹤0.01% |
531,302
-10
| -0% | -$246 |
|
|
AIV
1228
Aimco
AIV
$379M
| $13M | ﹤0.01% |
2,213,584
| – | – |
|
1229
Fluor
FLR
$7B
| $12.9M | ﹤0.01% |
261,114
+1,200
| +0.5% | +$62.4K |
|
1230
Under Armour Class C
UA
$2.25B
| $12.8M | ﹤0.01% |
+351,985
| New | +$13M |
|
1231
Galicia Financial Group
GGAL
$7.23B
| $12.8M | ﹤0.01% |
418,760
+19,600
| +5% | +$565K |
|
|
AMAG
1232
DELISTED
AMAG Pharmaceuticals
AMAG
| $12.8M | ﹤0.01% |
533,500
+13,120
| +3% | +$301K |
|
1233
Globe Life
GL
$14B
| $12.7M | ﹤0.01% |
205,771
+365
| +0.2% | +$21.3K |
|
|
LOGM
1234
DELISTED
LogMein, Inc.
LOGM
| $12.7M | ﹤0.01% |
199,969
+8,419
| +4% | +$486K |
|
|
FARO
1235
DELISTED
Faro Technologies
FARO
| $12.7M | ﹤0.01% |
374,440
-358,240
| -49% | -$11.8M |
|
|
BBBY
1236
DELISTED
Bed Bath & Beyond Inc
BBBY
| $12.7M | ﹤0.01% |
292,938
-7,410
| -2% | -$336K |
|
|
FCH
1237
DELISTED
Felcor Lodging Trust
FCH
| $12.6M | ﹤0.01% |
2,028,048
+88,200
| +5% | +$618K |
|
1238
Travere Therapeutics
TVTX
$5.79B
| $12.6M | ﹤0.01% |
708,689
-15,100
| -2% | -$244K |
|
|
PNRA
1239
DELISTED
Panera Bread Co
PNRA
| $12.6M | ﹤0.01% |
59,321
-513
| -0.9% | -$109K |
|
1240
Leggett & Platt
LEG
$1.32B
| $12.5M | ﹤0.01% |
245,436
-1,700
| -0.7% | -$83.7K |
|
1241
Donaldson
DCI
$11.1B
| $12.5M | ﹤0.01% |
363,833
-22,492
| -6% | -$751K |
|
1242
Sportsman's Warehouse
SPWH
$46.8M
| $12.4M | ﹤0.01% |
1,540,860
+2,300
| +0.1% | +$22.9K |
|
|
TRQ
1243
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $12.3M | ﹤0.01% |
364,915
+362,445
| +14,674% | +$10.5M |
|
1244
Qorvo
QRVO
$8.68B
| $12.3M | ﹤0.01% |
223,090
-3,500
| -2% | -$175K |
|
|
BPMC
1245
DELISTED
Blueprint Medicines
BPMC
| $12M | ﹤0.01% |
594,983
+83,175
| +16% | +$1.51M |
|
|
IRBT
1246
DELISTED
iRobot
IRBT
| $12M | ﹤0.01% |
342,316
-955,509
| -74% | -$35.1M |
|
1247
Inogen
INGN
$154M
| $12M | ﹤0.01% |
239,340
+19,100
| +9% | +$911K |
|
|
KITE
1248
DELISTED
Kite Pharma, Inc.
KITE
| $12M | ﹤0.01% |
239,742
+224,752
| +1,499% | +$11M |
|
1249
Goodyear
GT
$1.78B
| $12M | ﹤0.01% |
466,886
-3,400
| -0.7% | -$97.5K |
|
|
TPH
1250
DELISTED
Tri Pointe Homes
TPH
| $12M | ﹤0.01% |
1,012,560
-32,090
| -3% | -$376K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.